These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2894404)

  • 21. Reduction in cortical 5HT2 receptor sensitivity after continuous gepirone treatment.
    Eison AS; Yocca FD
    Eur J Pharmacol; 1985 May; 111(3):389-92. PubMed ID: 2862051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 5-HT1A selective anxiolytics on lordosis behavior: interactions with progesterone.
    Mendelson SD; Gorzalka BB
    Eur J Pharmacol; 1986 Dec; 132(2-3):323-6. PubMed ID: 2880737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus.
    Andrade R; Nicoll RA
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):5-10. PubMed ID: 2888027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5HT neurons.
    Mennini T; Gobbi M; Ponzio F; Garattini S
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):40-9. PubMed ID: 2421657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a postsynaptic action of the serotonergic anxiolytics: ipsapirone, indorenate and buspirone.
    Fernández-Guasti A; López-Rubalcava C; Pérez-Urizar J; Castañeda-Hernández G
    Brain Res Bull; 1992 Apr; 28(4):497-501. PubMed ID: 1352175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase.
    Fernández-Guasti A; Picazo O
    Pharmacol Biochem Behav; 1990 Sep; 37(1):77-81. PubMed ID: 1979876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brainstem 5-hydroxytrytamine1A binding sites are not down-regulated by agonists which induce tolerance in the rat: myoclonus and other serotonergic behaviors.
    Murthy JN; Pranzatelli MR
    J Recept Res; 1992; 12(3):287-97. PubMed ID: 1387164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurophysiological effects of buspirone and isapirone in the hippocampus: comparison with 5-hydroxytryptamine.
    Rowan MJ; Anwyl R
    Eur J Pharmacol; 1986 Dec; 132(1):93-6. PubMed ID: 2880731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzodiazepine anxiolytic action and affinities for serotonergic and adrenergic receptors.
    Fulton A; Burrows GD
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):33-7. PubMed ID: 6145186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biogenic amine alterations in limbic brain regions of muricidal rats.
    Broderick PA; Barr GA; Sharpless NS; Bridger WH
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):3-15. PubMed ID: 2581293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment.
    Yocca FD; Eison AS; Hyslop DK; Ryan E; Taylor DP; Gianutsos G
    Life Sci; 1991; 49(24):1777-85. PubMed ID: 1682780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chlorpheniramine on muricide induced by thiamine deficiency: pharmacokinetic and behavioral studies.
    Onodera K; Sakurai E; Niwa H
    Agents Actions; 1987 Apr; 20(3-4):229-32. PubMed ID: 3604802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the putative anxiolytic SM-3997 on central monoaminergic systems.
    Tatsuno T; Shimizu H; Hirose A; Tanaka H; Kumasaka Y; Nakamura M
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1049-55. PubMed ID: 2572002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites.
    Blackshear MA; Friedman RL; Sanders-Bush E
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):125-9. PubMed ID: 6646240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.
    Yocca FD
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):6S-12S. PubMed ID: 1973941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple serotonin receptors: regional distribution and effect of Raphe lesions.
    Blackshear MA; Steranka LR; Sanders-Bush E
    Eur J Pharmacol; 1981 Dec; 76(4):325-34. PubMed ID: 7327207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.